Symposiums

Cancer immunotherapy has moved to the forefront in the treatment of patients with cancer, providing a unique opportunity to achieve dramatic and…

Prof David Goldsmith opened the symposium by highlighting the objectives of the meeting. The education objectives of the symposium were to summarise the…

This symposium provided an overview of the current and future technologies and treatments used in the field of allergen immunotherapy (AIT).

Hereditary angioedema manifests as recurrent self-limiting episodes of angioedema, affecting the skin or mucosal tissues.

Prof Robin Foà opened the symposium by highlighting how improving healthcare and an ageing population are increasing the burden on healthcare resources…

A recent symposium at the European Hematology Association (EHA) congress, chaired by Prof Eva Kimby, explored the changing paradigms in the treatment of…

Several rare haematological diseases are linked to bone marrow failure (BMF). This symposium provided the latest scientific insights into the different…

The treatment landscape for patients with multiple myeloma (MM) is constantly evolving. Over the past decade, the introduction of novel agents including…